The present study extends previous observations on the acute treatment with alpha-glycerylphosphorylcholine (GPC), a putative acetylcholine (ACh) precursor, and investigates the effect of chronic treatment with this drug on scopolamine-induced amnesia and on ACh release in the rat. The drug acutely administered antagonizes the amnesic effect of scopolamine (0.75 mg/kg s.c.) in passive avoidance experiments. The effect peaked at 600 mg/kg i.g. and lasted up to 30 hr. Potassium-stimulated release of ACh from slices of hippocampus and cerebral cortex was measured after various doses of GPC. The dose curve study indicated that GPC was able to increase ACh release in the hippocampus already at the dose of 75 mg/kg i.g. The maximum effect was obtained with 300 mg/kg i.g. (147% of the control values). The increase of the ACh release reached a maximum 3 hr following the administration, then declined toward control values. In the cortex, the effect was much less pronounced and shorter than in the hippocampus. The repeated (100 and 300 mg/kg i.g.; 22 days) GPC administration effectively antagonized scopolamine-induced amnesia, indicating that there was no tolerance to this effect of GPC. While both doses were behaviorally active only 300 mg/kg was able to increase ACh release from hippocampus (+ 271%) and cortex (+ 57%). The data support the hypothesis that GPC improves behavioral performance in passive avoidance through an action on cholinergic transmission. On the other hand, it should be stressed that the action on ACh release is observed in a narrow time window in contrast to the long lasting effect on behavior. It is tempting to speculate that the effect on ACh may be related to cortical activation and important but not sufficient to explain the antagonism of scopolamine-induced amnesia. Along this line other mechanisms, possibly triggered by the action on ACh, may contribute to mediate the behavioral effect of GPC.

Govoni, S., Lopez, C., Battaini, F.m., Trabucchi, M.m. (1992). CHRONIC TREATMENT WITH AN ACETYLCHOLINE SYNTHESIS PRECURSOR, ALPHA-GLYCERYLPHOSPHORYLCHOLINE, ALTERS BRAIN PARAMETERS LINKED TO CHOLINERGIC TRANSMISSION AND PASSIVE-AVOIDANCE BEHAVIOR. DRUG DEVELOPMENT RESEARCH, 26(4), 439-447.

CHRONIC TREATMENT WITH AN ACETYLCHOLINE SYNTHESIS PRECURSOR, ALPHA-GLYCERYLPHOSPHORYLCHOLINE, ALTERS BRAIN PARAMETERS LINKED TO CHOLINERGIC TRANSMISSION AND PASSIVE-AVOIDANCE BEHAVIOR

BATTAINI, FIORENZO MARIA;TRABUCCHI, MARCO MARIO
1992-01-01

Abstract

The present study extends previous observations on the acute treatment with alpha-glycerylphosphorylcholine (GPC), a putative acetylcholine (ACh) precursor, and investigates the effect of chronic treatment with this drug on scopolamine-induced amnesia and on ACh release in the rat. The drug acutely administered antagonizes the amnesic effect of scopolamine (0.75 mg/kg s.c.) in passive avoidance experiments. The effect peaked at 600 mg/kg i.g. and lasted up to 30 hr. Potassium-stimulated release of ACh from slices of hippocampus and cerebral cortex was measured after various doses of GPC. The dose curve study indicated that GPC was able to increase ACh release in the hippocampus already at the dose of 75 mg/kg i.g. The maximum effect was obtained with 300 mg/kg i.g. (147% of the control values). The increase of the ACh release reached a maximum 3 hr following the administration, then declined toward control values. In the cortex, the effect was much less pronounced and shorter than in the hippocampus. The repeated (100 and 300 mg/kg i.g.; 22 days) GPC administration effectively antagonized scopolamine-induced amnesia, indicating that there was no tolerance to this effect of GPC. While both doses were behaviorally active only 300 mg/kg was able to increase ACh release from hippocampus (+ 271%) and cortex (+ 57%). The data support the hypothesis that GPC improves behavioral performance in passive avoidance through an action on cholinergic transmission. On the other hand, it should be stressed that the action on ACh release is observed in a narrow time window in contrast to the long lasting effect on behavior. It is tempting to speculate that the effect on ACh may be related to cortical activation and important but not sufficient to explain the antagonism of scopolamine-induced amnesia. Along this line other mechanisms, possibly triggered by the action on ACh, may contribute to mediate the behavioral effect of GPC.
1992
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore BIO/14 - FARMACOLOGIA
English
Con Impact Factor ISI
ACETYLCHOLINE RELEASE; ACETYLCHOLINE PRECURSORS; SCOPOLAMINE; PASSIVE AVOIDANCE; MEMORY
9
Govoni, S., Lopez, C., Battaini, F.m., Trabucchi, M.m. (1992). CHRONIC TREATMENT WITH AN ACETYLCHOLINE SYNTHESIS PRECURSOR, ALPHA-GLYCERYLPHOSPHORYLCHOLINE, ALTERS BRAIN PARAMETERS LINKED TO CHOLINERGIC TRANSMISSION AND PASSIVE-AVOIDANCE BEHAVIOR. DRUG DEVELOPMENT RESEARCH, 26(4), 439-447.
Govoni, S; Lopez, C; Battaini, Fm; Trabucchi, Mm
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/51573
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact